- Hodgkin Lymphoma
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Meet The Professor Sessions
- Chronic Myeloid Leukemia
- Myeloproliferative Neoplasms
- Breakfast With The Expert
- Independent Satellite Symposium
- Plenary Sessions
- Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Indolent B-cell Lymphoma
- Mantle Cell Lymphoma
- Aggressive B-cell Lymphoma
- T-cell Lymphoma
- Cellular Therapy
- Next Questions
- Events
Playback speed
10 seconds
The Promising Data on Efficacy of Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed AML
26 views
October 18, 2019
Login to view comments.
Click here to Login
Acute Myeloid Leukemia